More on BIIB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-41.6% Growth)
- Ratings (4.0 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/22/21 *Est.)
- Spin-Off (3/31/17 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BIIB Income Statement

Click line-items for a historical chart and %
Revenues:
Product 2.54B
Unconsolidated joint business
Other 98.6M
Total revenues 2.96B
Cost and expenses:
Cost of sales, excluding amortization of acquired intangible assets
Research and development
Selling, general and administrative 462.7M
Collaboration profit sharing
Amortization of acquired intangible assets 99.7M
Acquired in-process research and development
Restructuring charge 11.6M
Fair value adjustment of contingent consideration
Total cost and expenses 1.53B
Income from operations 1.43B
Other income (expense), net
Income before income tax expense 1.37B
Income tax expense 337M
Net income 1.03B
Net income attributable to noncontrolling interests, net of tax -2.7M
Net income attributable to Biogen Idec Inc. 1.03B
Net income per share:
Basic earnings per share attributable to Biogen Idec Inc. 4.72
Diluted earnings per share attributable to Biogen Idec Inc. 4.71
Weighted-average shares used in calculating:
Basic earnings per share attributable to Biogen Idec Inc. 218.9M
Diluted earnings per share attributable to Biogen Idec Inc. 219.4M